- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015, Section 1.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.—(1) These Regulations may be cited as the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015.
(2) Regulations 1 and 2 come into force on the day after the day on which these Regulations are made.
(3) Regulations 3 to 7 come into force on 1st October 2015.
(4) In these Regulations—
“ [F1UK] marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012 M1;
“medical device” has the meaning given by regulation 2(1) of the Medical Devices Regulations 2002 M2;
“medicinal product” has the meaning given by regulation 2(1) of the Human Medicines Regulations 2012;
“nicotine cartridge” means a cartridge which—
contains a substance which is not tobacco but consists of, or contains, nicotine M3, and
is intended to form part of a nicotine inhaling device;
“nicotine inhaling device” means a device which—
is intended to enable nicotine to be inhaled through a mouth piece (regardless of whether the device is also intended to enable any other substance to be inhaled through a mouth piece), but
is not tobacco, cigarette papers or a device intended to be used for the consumption of lit tobacco;
“nicotine inhaling product” means a nicotine inhaling device, nicotine cartridge or nicotine refill substance;
“nicotine refill substance” means a substance which—
is not tobacco but consists of, or contains, nicotine, and
is intended to be used to refill a nicotine inhaling device;
“parallel import licence” has the meaning given by regulation 48(2) of the Human Medicines Regulations 2012;
“prescription only medicine” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012.
Textual Amendments
F1Word in reg. 1(4) inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 8 para. 13(2); 2020 c. 1, Sch. 5 para. 1(1)
Marginal Citations
M1S.I. 2012/1916. .Relevant amendments were made by S.I. 2013/235, 1855, 2593, 2014/490, 1878.
M2S.I. 2002/618. Relevant amendments were made by S.I 2008/2936.
M3See the definition of “tobacco” at section 92(12) of the Children and Families Act 2014.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: